The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective

por Peretti, Umberto, Zanon, Silvia, Michele, Reni
Publicado 2017

Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma

por Trestini, Ilaria, Carbognin, Luisa, Peretti, Umberto, Sperduti, Isabella, Caldart, Alberto, Tregnago, Daniela, Avancini, Alice, Auriemma, Alessandra, Orsi, Giulia, Pilotto, Sara, Frulloni, Luca, Capurso, Gabriele, Bria, Emilio, Reni, Michele, Tortora, Giampaolo, Milella, Michele
Publicado 2021

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma

por Bria, Emilio, Pilotto, Sara, Amato, Eliana, Fassan, Matteo, Novello, Silvia, Peretti, Umberto, Vavalà, Tiziana, Kinspergher, Stefania, Righi, Luisella, Santo, Antonio, Brunelli, Matteo, Corbo, Vincenzo, Giglioli, Eliana, Sperduti, Isabella, Milella, Michele, Chilosi, Marco, Scarpa, Aldo, Tortora, Giampaolo
Publicado 2015